D. Russell

Most-cited papers

1. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

   P. Keown, P. Häyry, P. Morris, C. Stiller +32 more

   1996Transplantation1,034 citations Open access

   Semantic Scholar

   Save

2. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.

   P. Keown, D. Landsberg, P. Halloran, A. Shoker +16 more

   1996Transplantation194 citations Open access

   Semantic Scholar

   Save

3. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.

   E. Cole, D. Landsberg, D. Russell, J. Zaltzman +4 more

   2001Transplantation131 citations Open access

   Semantic Scholar

   Save

4. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

   E. Cole, Paul A. Keown, D. Landsberg, P. Halloran +18 more

   1998Transplantation67 citations Open access

   Semantic Scholar

   Save

5. Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation.

   D. Vethanayagam, S. Pugsley, Ej Dunn, D. Russell +2 more

   2000Canadian Respiratory Journal28 citations Open access

   Semantic Scholar

   Save

6. SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL TRANSPLANT RECIPIENTS

   E. Cole, P. Keown, D. Landsberg, P. Halloran +19 more

   199818 citations

   Semantic Scholar

   Save

7. RENAL TRANSPLANTATION WITHOUT STEROIDS ‐ ONE YEAR RESULTS OF A MULTICENTRE CANADIAN PILOT STUDY.: Abstract# 86

   D. Landsberg, E. Cole, D. Russell, J. Zaltzman +5 more

   200013 citations Open access

   Semantic Scholar

   Save

8. A prospective 3‐yr evaluation of tacrolimus‐based immunosuppressive therapy in immunological high risk renal allograft recipients

   J. Zaltzman, A. Boucher, S. Busque, Phillip F. Halloran +7 more

   2005Clinical Transplantation12 citations

   Semantic Scholar

   Save

9. Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients.

   J. Zaltzman, V. McAlister, D. Russell, P. Halloran +7 more

   2001Transplantation Proceedings4 citations

   Semantic Scholar

   Save

10. RENAL TRANSPLANTATION WITHOUT STEROIDS - A MULTICENTRE CANADIAN PILOT STUDY

    E. Cole, D. Landsberg, D. Russell, J. Zaltzman +2 more

    19993 citations Open access

    Semantic Scholar

    Save

11. P44 Stable pharmacokinetics and biochemical markers of IBD activity: results from real-world adalimumab biosimilar switching program

    Alice Moore, D. Russell, R. Dart, Shiluka Dias +6 more

    2022Poster presentations0 citations

    Semantic Scholar

    Save

12. TACROLIMUS, MMF, STEROID AND ALG IMMUNOTHERAPY FOR HIGH IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS.: THE CANADIAN MULTI‐CENTRE HIGH RISK RENAL TRANSPLANT STUDY.: Abstract# 15

    J. Zaltzman, V. McAlister, D. Russell, P. Halloran +7 more

    20000 citations

    Semantic Scholar

    Save